Anti-CLEC12A antibody-drug conjugate - ABL Bio Inc
Latest Information Update: 15 Jun 2023
At a glance
- Originator ABL Bio
- Class Antibodies; Antineoplastics; Benzodiazepines; Drug conjugates; Immunoconjugates; Pyrroles
- Mechanism of Action DNA cross linking agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer